We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Five Warning Letters, Citing CGMP Violations, Insanitary Conditions
FDA Issues Five Warning Letters, Citing CGMP Violations, Insanitary Conditions
The FDA issued a series of warning letters to three foreign and two U.S. drugmakers, faulting them for violations ranging from inadequate aseptic processing areas to use of APIs subject to an import alert.